13.12.2017 • NewsElaine BurridgeClariantCB&I

Clariant Wins China PDH Contract

The Catofin catalyst is used to produce olefins such as propylene or...
The Catofin catalyst is used to produce olefins such as propylene or isobutylene from light paraffin feedstocks. (c) twitter.com/clariant

Clariant and its US technology partner CB&I are developing a custom-built propane dehydrogenation (PDH) plant for China’s Xuzhou HaiDing Chemical Technology. The agreement includes a license and engineering design for a 600,000 t/y facility in Pizhou, Jiangsu province, China, based on Clariant’s Catofin catalyst and heat-generating material (HGM). A timescale for the project was not revealed.

The Catofin catalyst is used to produce olefins such as propylene or isobutylene from light paraffin feedstocks. HGM is a patented metal-oxide material loaded with the catalyst that increases the selectivity and yield of the Catofin units.

The contract follows another PDH project awarded to Clariant and CB&I in February this year by China’s Dongguan Grand Resource Science & Technology.

Globally, nine Catofin PDH units have been commissioned to date, producing more than 4.5 million t/y of propylene.

In separate news, the Swiss specialty chemicals producer is launching a 3D printing business to provide high-quality products for premium and customized printer filaments. The new business will support the fast-changing additive manufacturing technology, which supplies complex end-use products such as air ducts, drones, lights and parts for manufacturing equipment.

The Muttenz-based group said it will work closely with customers on polymer, additive and colorant selection to address typical end-use conditions such as weathering, flame retardancy and electrical properties.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.